Stenosis or dysfunctional motility at the sphincter of Oddi leading to pancreatic or biliary obstruction.
- Epidemiology & Risk Factors
- More common in women (F:M = 4:1).
- Age 30-50 yrs.
- Post-cholecystectomy syndrome (pain persists after cholecystectomy).
- History of pancreatitis.
- Types: Biliary SOD (affects bile flow) vs Pancreatic SOD (affects pancreatic duct drainage).
- Clinical Features
- Biliary-type pain: RUQ/epigastric pain lasting >30 min, often postprandial.
- Radiation to back/right scapula.
- ± Nausea/vomiting.
- Recurrent episodes (not constant).
- No relief with bowel movements or antacids.
- Often post-cholecystectomy (pain similar to pre-op gallbladder pain).
- Diagnosis
- Classification (Milwaukee criteria):
- Type I: Pain + ↑ LFTs (AST/ALT, ALP, bili) + Dilated CBD (>12mm on US). High likelihood of SOD.
- Type II: Pain + only 1-2 of above criteria.
- Type III: Pain alone, no objective findings (most controversial).
- Initial: RUQ US (r/o retained stone, check CBD diameter), LFTs during pain episode.
- Key Labs: Transient ↑ AST/ALT, ↑ ALP, ↑ amylase/lipase (if pancreatic type).
- Confirmatory/Gold Standard: Sphincter of Oddi manometry (SOM) during ERCP (measures sphincter pressure). Abnormal if basal pressure >40 mmHg.
- Alternative: Hepatobiliary scintigraphy (HIDA scan) may show delayed biliary drainage.
- MRCP: R/o structural obstruction (stricture, stones, malignancy).
- Classification (Milwaukee criteria):
- Differential Diagnostics
- Retained/Recurrent CBD stone: Diff by MRCP/ERCP showing filling defect; US may show dilated CBD.
- Biliary stricture: Diff by persistent CBD dilation, progressive jaundice; MRCP shows stricture.
- Chronic pancreatitis: Diff by calcifications on CT, ductal changes on MRCP, exocrine/endocrine insufficiency.
- Peptic ulcer disease: Diff by epigastric pain relieved by food/antacids, EGD findings.
- Functional dyspepsia: Diff by absence of objective findings, no postprandial pattern specific to biliary tree.
- Management
- Type I SOD (high likelihood):
- ERCP with biliary sphincterotomy (70-90% response rate).
- Consider pancreatic sphincterotomy if pancreatic-type symptoms.
- Type II SOD:
- Trial of smooth muscle relaxants (e.g., CCBs, nitrates) or observation.
- If refractory + documented elevated sphincter pressure on manometry → ERCP with sphincterotomy.
- Type III SOD (controversial):
- Avoid ERCP (recent trials show sphincterotomy no better than sham in Type III).
- Medical management: Tricyclic antidepressants (nortriptyline), neuromodulators.
- Psychotherapy/pain management.
- General: Avoid opioids (can worsen sphincter spasm).
- Type I SOD (high likelihood):